Cardiff Oncology appoints Leila Alland as interim chief medical officer

Cardiff Oncology appointed Leila Alland interim chief medical officer, replacing Roger Sidhu, who stepped down. Alland previously served as chief medical officer at PMV Pharma, Affimed and Tarveda Therapeutics.

1. Leadership change

Cardiff Oncology appointed Leila Alland interim chief medical officer, replacing Roger Sidhu, who stepped down. Alland previously served as chief medical officer at PMV Pharma, Affimed and Tarveda Therapeutics.

1. Leadership change

Related News

Ribbon Communications forecasts 2026 revenue of $807 million to $821 million

Bitdeer Technologies Group updates financial calendar

Saba Capital Management reports $29,923.74 acquisition of Ellsworth Growth and Income Fund common shares

Baker Hughes rounds out oilfield services earnings with lower Q3 profit

Ball declares quarterly dividend of 20 cents per share